Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kaiyuan Yu, Luxia Xiang, Shaoxun Li, Shuaibin Wang, Chaohao Chen & Haiqi Mu. (2019) HIF1α promotes prostate cancer progression by increasing ATG5 expression. Animal Cells and Systems 23:5, pages 326-334.
Read now
Read now
Articles from other publishers (30)
Richard Ottman, Kavya Ganapathy, Hui-Yi Lin, Carlos Diaz Osterman, Julie Dutil, Jaime Matta, Gilberto Ruiz-Deya, Liang Wang, Kosj Yamoah, Anders Berglund, Ratna Chakrabarti & Jong Y. Park. (2023) Differential Expression of miRNAs Contributes to Tumor Aggressiveness and Racial Disparity in African American Men with Prostate Cancer. Cancers 15:8, pages 2331.
Crossref
Crossref
Jaroslav Juracek, Marie Madrzyk, Michal Stanik, Michaela Ruckova, Karolina Trachtova, Hana Malcikova, Eva Lzicarova, Dominik A. Barth, Martin Pichler & Ondrej Slaby. (2022) A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer. The Prostate 83:4, pages 340-351.
Crossref
Crossref
Muhammad Bilal, Aqsa Javaid, Farhat Amjad, Tamer Abou Youssif & Samia Afzal. (2022) An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs. Translational Oncology 26, pages 101542.
Crossref
Crossref
Lan Guo, Shuai Chen, Yong-Liang Yu & Jian-Hua Wang. (2021)
A Smartphone Optical Device for Point-of-Care Testing of Glucose and Cholesterol Using Ag NPs/UiO-66-NH
2
-Based Ratiometric Fluorescent Probe
. Analytical Chemistry 93:48, pages 16240-16247.
Crossref
Crossref
Arun Richard Chandrasekaran & Ken Halvorsen. (2021) DNA-Based Smart Reagent for Detecting Alzheimer’s Associated MicroRNAs. ACS Sensors 6:9, pages 3176-3181.
Crossref
Crossref
Arun Richard Chandrasekaran, Molly MacIsaac, Javier Vilcapoma, Clinton H. Hansen, Darren Yang, Wesley P. Wong & Ken Halvorsen. (2021) DNA Nanoswitch Barcodes for Multiplexed Biomarker Profiling. Nano Letters 21:1, pages 469-475.
Crossref
Crossref
Martyna Parol, Arkadiusz Gzil, Magdalena Bodnar & Dariusz Grzanka. (2021) Systematic review and meta-analysis of the prognostic significance of microRNAs related to metastatic and EMT process among prostate cancer patients. Journal of Translational Medicine 19:1.
Crossref
Crossref
Setareh Rezatabar, Emadoddin Moudi, Farzin Sadeghi, Soraya Khafri, Tayebeh Azramezani Kopi & Hadi Parsian. (2020) Evaluation of the plasma level of long non‐coding RNA PCAT1 in prostatic hyperplasia and newly diagnosed prostate cancer patients. The Journal of Gene Medicine 22:10.
Crossref
Crossref
Maria Yu. Konoshenko, Evgeniy A. Lekchnov, Olga E. Bryzgunova, Ivan A. Zaporozhchenko, Sergey V. Yarmoschuk, Oksana A. Pashkovskaya, Svetlana V. Pak & Pavel P. Laktionov. (2020) The Panel of 12 Cell-Free MicroRNAs as Potential Biomarkers in Prostate Neoplasms. Diagnostics 10:1, pages 38.
Crossref
Crossref
Sadegh Amiri, Beheshteh Abouhamzeh, Iraj Mirzaii-Dizgah, Seyed Reza Yahyazadeh, Mohsen Sokounati & Fatemeh Amiri. (2019) Serum Lysophosphatidic Acid as a Potential Biomarker of Prostate Cancer. Annals of Military and Health Sciences Research 17:3.
Crossref
Crossref
Francesco Greco, Antonino Inferrera, Roberto La Rocca, Michele Navarra, Marco Casciaro, Gaetano Grosso, Sebastiano Gangemi, Vincenzo Ficarra & Vincenzo Mirone. (2019) The Potential Role of MicroRNAs as Biomarkers in Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis. European Urology Focus 5:3, pages 497-507.
Crossref
Crossref
Maryam Khorasani, Ladan Teimoori-Toolabi, Taghi Naserpour Farivar, Mojgan Asgari, Maryam Abolhasani, Hossein Shahrokh, Ali Afgar, Elham Kalantari, Amir Peymani & Reza Mahdian. (2018) Aberrant expression of miR-141 and nuclear receptor small heterodimer partner in clinical samples of prostate cancer. Cancer Biomarkers 22:1, pages 19-28.
Crossref
Crossref
Chun‐Jiao Song, Huan Chen, Li‐Zhong Chen, Guo‐Mei Ru, Jian‐Jun Guo & Qian‐Nan Ding. (2017) The potential of microRNAs as human prostate cancer biomarkers: A meta‐analysis of related studies. Journal of Cellular Biochemistry 119:3, pages 2763-2786.
Crossref
Crossref
Hung N. Luu, Hui-Yi Lin, Karina Dalsgaard Sørensen, Olorunseun O. Ogunwobi, Nagi Kumar, Ganna Chornokur, Catherine Phelan, Dominique Jones, LaCreis Kidd, Jyotsna Batra, Kosj Yamoah, Anders Berglund, Robert J. Rounbehler, Mihi Yang, Sang Haak Lee, Nahyeon Kang, Seung Joon Kim, Jong Y. Park & Giuliano Di Pietro. (2017) miRNAs associated with prostate cancer risk and progression. BMC Urology 17:1.
Crossref
Crossref
Yuan Zhao, Zhiqiang Ling, Yubin Hao, Xiaowu Pang, Xianlin Han, Joseph A. Califano, Liang Shan & Xinbin Gu. (2017) MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma. Oncotarget 8:15, pages 25005-25020.
Crossref
Crossref
Can Liu, Ruifang Liu, Dingxiao Zhang, Qu Deng, Bigang Liu, Hsueh-Ping Chao, Kiera Rycaj, Yoko Takata, Kevin Lin, Yue Lu, Yi Zhong, John Krolewski, Jianjun Shen & Dean G. Tang. (2017) MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes. Nature Communications 8:1.
Crossref
Crossref
Niels Asger Jakobsen, Freddie Charles Hamdy & Richard John Bryant. (2016) Novel biomarkers for the detection of prostate cancer. Journal of Clinical Urology 9:2_suppl, pages 3-10.
Crossref
Crossref
Benjamin L Jackson, Anna Grabowska & Hari L Ratan. (2014) MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers. BMC Cancer 14:1.
Crossref
Crossref
Juliana Inês Santos, Ana Luísa Teixeira, Francisca Dias, Mónica Gomes, Augusto Nogueira, Joana Assis & Rui Medeiros. (2014) Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development. Tumor Biology 35:7, pages 6245-6253.
Crossref
Crossref
LI BING ZHU, SHENG TAO ZHAO, TING ZHAO XU & HE WANG. (2014) Tumor necrosis factor-α-induced a disintegrin and metalloprotease 10 increases apoptosis resistance in prostate cancer cells. Oncology Letters 7:3, pages 897-901.
Crossref
Crossref
Y-X Fang & W-Q Gao. (2013) Roles of microRNAs during prostatic tumorigenesis and tumor progression. Oncogene 33:2, pages 135-147.
Crossref
Crossref
Karen Chiam, Carmela Ricciardelli & Tina Bianco-Miotto. (2014) Epigenetic biomarkers in prostate cancer: Current and future uses. Cancer Letters 342:2, pages 248-256.
Crossref
Crossref
Akira Watahiki, Robyn Macfarlane, Martin Gleave, Francesco Crea, Yuzhuo Wang, Cheryl Helgason & Kim Chi. (2013) Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer. International Journal of Molecular Sciences 14:4, pages 7757-7770.
Crossref
Crossref
V Coppola, M Musumeci, M Patrizii, A Cannistraci, A Addario, M Maugeri-Saccà, M Biffoni, F Francescangeli, M Cordenonsi, S Piccolo, L Memeo, A Pagliuca, G Muto, A Zeuner, R De Maria & D Bonci. (2012) BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial–mesenchymal transition. Oncogene 32:14, pages 1843-1853.
Crossref
Crossref
Yong Huang, You Bing Yang, Xiao Hui Zhang, Xue Li Yu, Zhan Bin Wang & Xiang Chao Cheng. (2013) MicroRNA-21 gene and cancer. Medical Oncology 30:1.
Crossref
Crossref
Oudai Hassan, Aamir Ahmad, Seema Sethi & Fazlul H Sarkar. (2012) Recent updates on the role of microRNAs in prostate cancer. Journal of Hematology & Oncology 5:1.
Crossref
Crossref
Nicole M.A. White, Youssef M. Youssef, Annika Fendler, Carsten Stephan, Klaus Jung & George M. Yousef. (2012) The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer. Biological Chemistry 393:5.
Crossref
Crossref
Sung-Chou Li, Kuo-Wang Tsai, Hung-Wei Pan, Yung-Ming Jeng, Meng-Ru Ho & Wen-Hsiung Li. (2012) MicroRNA 3' end nucleotide modification patterns and arm selection preference in liver tissues. BMC Systems Biology 6:Suppl 2, pages S14.
Crossref
Crossref
Suyin P. Chin, Joanne L. Dickinson & Adele F. Holloway. (2011) Epigenetic regulation of prostate cancer. Clinical Epigenetics 2:2, pages 151-169.
Crossref
Crossref
Ammad Ahmad Farooqi, Shahzad Bhatti, Ali Nawaz & Ahmad Mukhtar Khalid. (2018) One Size Fits All in Prostate Cancer: A Story Tale Whose Time has Come and Gone. The International Journal of Biological Markers 26:2, pages 75-81.
Crossref
Crossref